Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Lebrikizumab> ?p ?o }
Showing triples 1 to 87 of
87
with 100 triples per page.
- Lebrikizumab abstract "Lebrikizumab (INN) is a humanized monoclonal antibody and an experimental immunosuppressive drug for the treatment of asthma that cannot be adequately controlled with inhalable glucocorticoids. The drug was created by Tanox under the name TNX-650, and a phase I clinical trial for refractory Hodgkin’s lymphoma had been performed when Genentech acquired Tanox in 2007. It has successfully completed a Phase II clinical trial for the treatment of asthma.".
- Lebrikizumab atcPrefix "none".
- Lebrikizumab casNumber "953400-68-5".
- Lebrikizumab fdaUniiCode "U9JLP7V031".
- Lebrikizumab wikiPageID "12597718".
- Lebrikizumab wikiPageLength "5262".
- Lebrikizumab wikiPageOutDegree "24".
- Lebrikizumab wikiPageRevisionID "678191721".
- Lebrikizumab wikiPageWikiLink Asthma.
- Lebrikizumab wikiPageWikiLink Bronchi.
- Lebrikizumab wikiPageWikiLink Bronchial_hyperresponsiveness.
- Lebrikizumab wikiPageWikiLink Bronchus.
- Lebrikizumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Lebrikizumab wikiPageWikiLink Cell_growth.
- Lebrikizumab wikiPageWikiLink Cell_proliferation.
- Lebrikizumab wikiPageWikiLink Clinical_trial.
- Lebrikizumab wikiPageWikiLink Cytokine.
- Lebrikizumab wikiPageWikiLink Epithelial_cell.
- Lebrikizumab wikiPageWikiLink Epithelium.
- Lebrikizumab wikiPageWikiLink FEV1.
- Lebrikizumab wikiPageWikiLink Fibroblast.
- Lebrikizumab wikiPageWikiLink Genentech.
- Lebrikizumab wikiPageWikiLink Glucocorticoid.
- Lebrikizumab wikiPageWikiLink Hodgkins_lymphoma.
- Lebrikizumab wikiPageWikiLink Hodgkin’s_lymphoma.
- Lebrikizumab wikiPageWikiLink Humanized_antibody.
- Lebrikizumab wikiPageWikiLink Humanized_monoclonal_antibody.
- Lebrikizumab wikiPageWikiLink Immunosuppressive_drug.
- Lebrikizumab wikiPageWikiLink Interleukin_13.
- Lebrikizumab wikiPageWikiLink International_Nonproprietary_Name.
- Lebrikizumab wikiPageWikiLink Periostin.
- Lebrikizumab wikiPageWikiLink Placebo.
- Lebrikizumab wikiPageWikiLink Spirometry.
- Lebrikizumab wikiPageWikiLink Subcutaneous_injection.
- Lebrikizumab wikiPageWikiLink T_helper_cell.
- Lebrikizumab wikiPageWikiLink Tanox.
- Lebrikizumab wikiPageWikiLink Th2_cell.
- Lebrikizumab wikiPageWikiLink White_blood_cell.
- Lebrikizumab wikiPageWikiLinkText "Lebrikizumab".
- Lebrikizumab wikiPageWikiLinkText "lebrikizumab".
- Lebrikizumab atcPrefix "none".
- Lebrikizumab c "6434".
- Lebrikizumab casNumber "953400".
- Lebrikizumab chemspiderid "NA".
- Lebrikizumab h "9972".
- Lebrikizumab hasPhotoCollection Lebrikizumab.
- Lebrikizumab kegg "D09633".
- Lebrikizumab legalStatus "Investigational".
- Lebrikizumab mabType "mab".
- Lebrikizumab n "1700".
- Lebrikizumab o "2034".
- Lebrikizumab pubchemsubstance "124490373".
- Lebrikizumab routesOfAdministration Subcutaneous_injection.
- Lebrikizumab s "50".
- Lebrikizumab source "zu".
- Lebrikizumab synonyms "MILR1444A, RG3637".
- Lebrikizumab target Interleukin_13.
- Lebrikizumab type "mab".
- Lebrikizumab unii "U9JLP7V031".
- Lebrikizumab verifiedfields "changed".
- Lebrikizumab verifiedrevid "458270514".
- Lebrikizumab watchedfields "changed".
- Lebrikizumab wikiPageUsesTemplate Template:Drugbox.
- Lebrikizumab wikiPageUsesTemplate Template:Immunosuppressants.
- Lebrikizumab wikiPageUsesTemplate Template:Monoclonals_for_immune_system.
- Lebrikizumab wikiPageUsesTemplate Template:Reflist.
- Lebrikizumab subject Category:Monoclonal_antibodies.
- Lebrikizumab hypernym Antibody.
- Lebrikizumab type Article.
- Lebrikizumab type ChemicalSubstance.
- Lebrikizumab type Drug.
- Lebrikizumab type Antibody.
- Lebrikizumab type Article.
- Lebrikizumab type Chemical.
- Lebrikizumab type Drug.
- Lebrikizumab type ChemicalObject.
- Lebrikizumab type Thing.
- Lebrikizumab type Q8386.
- Lebrikizumab comment "Lebrikizumab (INN) is a humanized monoclonal antibody and an experimental immunosuppressive drug for the treatment of asthma that cannot be adequately controlled with inhalable glucocorticoids. The drug was created by Tanox under the name TNX-650, and a phase I clinical trial for refractory Hodgkin’s lymphoma had been performed when Genentech acquired Tanox in 2007. It has successfully completed a Phase II clinical trial for the treatment of asthma.".
- Lebrikizumab label "Lebrikizumab".
- Lebrikizumab sameAs لبريكيزوماب.
- Lebrikizumab sameAs Lebrikizumab.
- Lebrikizumab sameAs m.02wx78d.
- Lebrikizumab sameAs Q3829321.
- Lebrikizumab sameAs Q3829321.
- Lebrikizumab wasDerivedFrom Lebrikizumab?oldid=678191721.
- Lebrikizumab isPrimaryTopicOf Lebrikizumab.